Mariner, LLC Biomarin Pharmaceutical Inc Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mariner, LLC holds 16,750 shares of BMRN stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,750

Previous 22,180 24.48%

Holding current value

$1.12 Million

Previous $1.83 Million 35.54%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $374,778 - $509,551	-5,430 Reduced 24.48%	16,750 $1.18 Million
Q2 2024 Aug 13, 2024	SELL	$74.43 - $92.22 $189,201 - $234,423	-2,542 Reduced 10.28%	22,180 $1.83 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $230,309 - $272,052	-2,748 Reduced 10.0%	24,722 $2.16 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $1,600 - $2,068	-21 Reduced 0.08%	27,470 $2.65 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $198,723 - $220,705	2,336 Added 9.29%	27,491 $2.43 Million
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $201,184 - $232,796	2,321 Added 10.16%	25,155 $2.18 Million
Q1 2023 May 12, 2023	SELL	$87.74 - $117.27 $207,505 - $277,343	-2,365 Reduced 9.39%	22,834 $2.22 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $24,521 - $32,914	-303 Reduced 1.19%	25,199 $2.61 Million
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $4,765 - $5,622	58 Added 0.23%	25,502 $2.16 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $98,928 - $120,200	1,384 Added 5.75%	25,444 $2.11 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $320,369 - $399,771	4,313 Added 21.84%	24,060 $1.86 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $514,088 - $655,656	7,168 Added 56.98%	19,747 $1.75 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $254,068 - $290,427	-3,398 Reduced 21.27%	12,579 $972,000
Q2 2021 Aug 24, 2021	SELL	$75.51 - $84.79 $52,932 - $59,437	-701 Reduced 4.2%	15,977 $1.33 Million
Q1 2021 May 07, 2021	SELL	$74.73 - $90.69 $644,845 - $782,564	-8,629 Reduced 34.1%	16,678 $1.26 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $720,218 - $894,693	9,919 Added 64.46%	25,307 $2.22 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $503 - $917	7 Added 0.05%	15,388 $1.17 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $34,126 - $53,290	429 Added 2.87%	15,381 $1.9 Million
Q1 2020 May 14, 2020	SELL	$71.37 - $96.85 $187,203 - $254,037	-2,623 Reduced 14.92%	14,952 $1.26 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $41,711 - $56,054	649 Added 3.83%	17,575 $1.49 Million
Q3 2019 Nov 13, 2019	BUY	$67.4 - $85.11 $149,830 - $189,199	2,223 Added 15.12%	16,926 $1.14 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $174,841 - $204,326	2,176 Added 17.37%	14,703 $1.26 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $673 - $788	8 Added 0.06%	12,527 $1.11 Million
Q4 2018 Feb 13, 2019	BUY	$80.14 - $106.07 $8,014 - $10,607	100 Added 0.81%	12,519 $1.07 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $37,568 - $42,288	-400 Reduced 3.12%	12,419 $1.2 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $79,202 - $103,189	1,042 Added 8.85%	12,819 $1.21 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $58,640 - $69,935	-755 Reduced 6.02%	11,777 $955,000
Q4 2017 Feb 09, 2018	BUY	$80.76 - $95.13 $1.01 Million - $1.19 Million	12,532	12,532 $1.12 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account